Transplant Milestone: Liver Recipient No Longer Needs Prograf

March 23, 2010

Eric Lindquester took daily anti-rejection medications for 14 years. But thanks to a study at Children’s Hospital of Pittsburgh, those days are over.

Born with biliary atresia, a rare and life-threatening liver disease, Eric received a liver transplant in 1990. He was only 5 months old. Today, Eric is an honor student and Eagle Scout, in his freshman year of college.

Eric was one of the first patients to take the drug now known as Prograf, commonly prescribed as an immunosuppressant for transplant recipients. When he learned about the trial study at Children’s Hospital, he jumped at the chance to wean himself off his anti-rejection medications. The weaning process took two years, but Eric has been Prograf-free for five years – and he’s doing great!